FDA’s Emergency Research Regs Will Update “Community Informed Consent”
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is open to “possibilities” in terms of revising human subject protections.
You may also be interested in...
Sen. Grassley Presses HHS On Ethics Of FDA-Approved Blood Substitute Study
Grassley wants an investigation into FDA’s approval of a protocol that allowed patients to be treated with a blood substitute even though blood was available.
FDA Should Relax Endpoint Requirements For Emergency Research, Novo Nordisk Says
“Reduction of substantial morbidity alone should be sufficient” benefit in medical trials conducted under emergency conditions, the firm says.
Sen. Grassley Presses HHS On Ethics Of FDA-Approved Blood Substitute Study
Grassley wants an investigation into FDA’s approval of a protocol that allowed patients to be treated with a blood substitute even though blood was available.